Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-08

Study Completion Date

2018-06-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Every year in France, more than 60 000 people are operated for benign prostatic hyperplasia (BPH). This surgery is accompanied by a change or even a loss of ejaculations externalized what constitutes the main constraint for patients. Empirically, the investigators talk to the patient "retrograde ejaculation" to explain a possible loss of ejaculation. Yet the underlying mechanism of this modification or loss of ejaculation remains completely unknown. Yet the underlying mechanism of this modification or loss of ejaculation remains completely unknown. No study could not determine whether the predominant mechanism was a real retrograde ejaculation or aspermia. Moreover, technical changes are sometimes tempted to preserve antegrade ejaculation but no scientific rationale can not validate.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction

NCT05574244

Benign Prostatic Hyperplasia

RECRUITING NA

Benign Prostate Surgery and QOL and Sexual Function

NCT05826691

Quality of Life Sexual Dysfunction Ejaculatory Dysfunction +3 more

UNKNOWN

Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate

NCT05914519

Ejaculatory Dysfunction BPH

COMPLETED NA

Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia

NCT02822924

Benign Prostate Hyperplasia

COMPLETED NA

Impact of Intraoperative Instillation of Normothermal Saline on the Prevention of Intraoperative Hypothermia and Perioperative Morbidity of Prostatic Enucleation With Holmium Laser

NCT04761224

Prostatic Hypertrophy

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Every year in France, more than 60 000 people are operated for benign prostatic hyperplasia (BPH). This surgery is accompanied by a change or even a loss of ejaculations externalized what constitutes the main constraint for patients. Empirically, the investigators talk to the patient "retrograde ejaculation" to explain a possible loss of ejaculation. Yet the underlying mechanism of this modification or loss of ejaculation remains completely unknown. No study could not determine whether the predominant mechanism was a real retrograde ejaculation or aspermia. Moreover, technical changes are sometimes tempted to preserve antegrade ejaculation but no scientific rationale can not validate.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Ejaculation Benign Prostatic Hyperplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Search retrograde ejaculation

Sperm count (spz) after orgasm achieved by masturbation will be measured, corresponding to the sum of spz collected in the ejaculate (E) and the first urine after orgasm (U). These measures will be made before surgery (E1 and U1) and after surgery (E2 and U2). The values E1, E2, U1 and U2 will be achieved by multiplying the concentration of spz per unit volume by the total volume of collection.

Group Type EXPERIMENTAL

Search retrograde ejaculation

Intervention Type PROCEDURE

Sperm count (spz) after orgasm achieved by masturbation will be measured, corresponding to the sum of spz collected in the ejaculate (E) and the first urine after orgasm (U). These measures will be made before surgery (E1 and U1) and after surgery (E2 and U2). The values E1, E2, U1 and U2 will be achieved by multiplying the concentration of spz per unit volume by the total volume of collection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Search retrograde ejaculation

Sperm count (spz) after orgasm achieved by masturbation will be measured, corresponding to the sum of spz collected in the ejaculate (E) and the first urine after orgasm (U). These measures will be made before surgery (E1 and U1) and after surgery (E2 and U2). The values E1, E2, U1 and U2 will be achieved by multiplying the concentration of spz per unit volume by the total volume of collection.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Man, at least 18 years, which is scheduled for a BPH surgery
* Sexually active
* Measurement of Residual postvoid less than 6 months
* Patients accepting the constraints of the study
* Signed Consent
* Affiliate or beneficiary of social security system.

Exclusion Criteria

* Patients unable to understand the study or to give consent
* Patients with known infertility
* Patients previously operated prostate
* Patients previously treated with a natural prostate treatment (radiotherapy, microwave, radio frequency, ultrasound)
* Patients with known urethral stenosis before surgery
* Patient with impaired preoperative in ejaculation
* Patient under guardianship or under judicial protection
* Patient subject to psychiatric care

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No